Name | 4-(4-acetylphenyl)-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]benzamide |
---|---|
Synonyms |
4'-Acetyl-N-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}biphenyl-4-carboxamide
4'-Acetyl-N-{4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl}-4-biphenylcarboxamide Tocris-1109 [1,1'-Biphenyl]-4-carboxamide, 4'-acetyl-N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- MFCD00936840 |
Description | GR 103691 is a potent, selective dopamine D3 receptor antagonist with a Ki value of 0.4 nM. GR 103691 shows more than 100-fold selectivity for human dopamine human (h)D3 over hD4 and hD1 sites[1]. |
---|---|
Related Catalog | |
Target |
Ki: 0.4 nM (Human dopamine D3 receptor)[1] |
In Vitro | GR 103691 shows marked affinity for serotonin1A (5-HT1A) receptors (Ki of 5.8 nM) and α-1 adrenoceptors (Ki of 12.6 nM)[1]. |
References |
Density | 1.1±0.1 g/cm3 |
---|---|
Boiling Point | 688.7±55.0 °C at 760 mmHg |
Molecular Formula | C30H35N3O3 |
Molecular Weight | 485.617 |
Flash Point | 370.3±31.5 °C |
Exact Mass | 485.267853 |
PSA | 61.88000 |
LogP | 4.47 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.582 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
Safety Phrases | S22-S24/25 |
RIDADR | NONH for all modes of transport |